PCRX (Pacira BioSciences) Company Cash Volume

Symbol and logo of brand Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences generates revenue through Exparel, overcoming generic pressure via marketing. The company's cash position demonstrates current liquidity, with the value fixed at 0.31. Growth potential is supported by patents for extended-release agents and the complexities of implementing new protocols. Stability is ensured by a strong staff of experts motivated by high compensation and the ethical goals of medicine.

Pacira Pharmaceuticals - PCRX Company Cash Balance (period 07/04/2022 - 11/21/2026)

Analytical breakdowns and data insights for company Pacira Pharmaceuticals (PCRX)

- stock value and consensus price forecast:
- business market valuation indicators:
Analysis of all company metrics:PCRX pacira.com
Brand item of Pacira BioSciences, Inc.

Steady hospital demand for Pacira BioSciences (PCRX) analgesics generates a reliable liquidity inflow, which is reflected in the trend of available cash. By analyzing this cash position chart, an investor assesses the total volume of cash and cash equivalents, allowing for a determination of the balance between the company's financial stability and the efficiency of capital allocation in new projects.

Main competitors

Company Cash Funds Haleon (HLN)|Company Cash Volume Kenvue Inc. (KVUE)|Company Cash Volume VRNA (veronapharma.com)|Company Cash Balance MENS|LGND: Company Cash on Hand|Company Cash Balance AMRX (Amneal Corp)|PRGO (Perrigo Company plc) - Company Cash on Hand|Alvotech - Company Cash Balance|Company Cash on Hand LQDA|Galapagos Genomics (GLPG) - Company Liquid Assets|Company Cash Volume ANIP|Company Cash on Hand Afrezza MNKD|Company Cash Funds Amphastar AMPH|SPRY - Company Cash on Hand|Theravance Biopharma, Inc. - Company Cash Volume|Company Cash Balance AQST (Aquestive Therapeutics, Inc.)|SCPH: Company Cash Volume|Tectonic Therapeutic Inc. - Company Cash Balance|TNXP (Tonix Pharma) - Company Cash Volume|SXTC: Company Cash Balance|Company Cash Volume EPRX|BHST - Company Cash Reserve|eXoZymes - Company Cash on Hand|Company Cash Volume oramed.com ORMP|ENTX - Company Cash Funds|Company Liquid Assets MindWalk Holdings HYFT|ABVC: Company Cash Volume|Company Cash on Hand Cumberland Pharmaceuticals Inc.|Company Cash Funds Quantum BioPharma Limited|FGEN: Company Cash Balance|Company Cash Volume TELO|Rani Therapeutics Holdings, Inc. - Company Cash and Cash Equivalents|Company Cash Funds Synergy CHC Corp. SNYR|Company Cash Balance RLYB|LEXX: Company Cash on Hand|Company Cash Balance PULM (Pulmatrix Corporation)|Pheton Holdings Limited (PTHL) - Company Cash Funds|Company Cash on Hand Aptorum|Company Cash on Hand LYRA|Impact BioMedical Inc - Company Total Cash Volume|Company Cash Volume TNFA|YCBD - Company Cash Reserve|PainReform Ltd. - Company Cash on Hand|CYTO (Auris Medical) - Company Total Cash Volume|LIPO - Company Cash Funds|Company Cash Balance OPTN (OptiNose)|PIRS: Company Cash Volume|Procaps Group S.A. (PROC) - Company Cash Volume|PTPI (Petros Pharma) - Company Cash Volume|QLI: Company Cash Balance|Company Cash Volume SLRN|TFFP (TFF Pharmaceuticals Inc.) - Company Cash Balance